有価証券レコード · アーカイブ済み四半期
TAK
Takeda Pharmaceutical Company Limited · Healthcare · Drug Manufacturers - Specialty & Generic
14追跡対象保有者
+2Δ保有者数
31.18M保有株数
$456.42M報告済み評価額
+3新規ポジション
−1解消銘柄
モメンタム指標（同類マネージャー）：
保有者の広がり +16.7% ·
株式フロー -1.0% ·
新規ネットポジション数 +14.3%
— 計算式
保有の分散化 — 保有者数の増加、合計持分の縮小
すべての保有状況データ：追跡対象13Fマネージャーのみ、普通株ポジション、報告期間 Q3 2025
保有状況の推移
| 四半期 | 保有者 | Δ | 株数 | 報告済み評価額 | 新規 | 解消銘柄 |
|---|---|---|---|---|---|---|
| Q2 2026 | 87 | +7 | 88.72M | $1.46B | +9 | −2 |
| Q1 2026 | 81 | +2 | 81.32M | $1.54B | +7 | −5 |
| Q4 2025 | 79 | -2 | 68.50M | $1.10B | — | −2 |
| Q3 2025 | 14 | +2 | 31.18M | $456.42M | +3 | −1 |
| Q2 2025 | 9 | -3 | 18.36M | $283.88M | — | −3 |
| Q1 2025 | 9 | +1 | 8.73M | $129.81M | +2 | −1 |
| Q4 2024 | 8 | +3 | 9.62M | $127.30M | +4 | −1 |
| Q3 2024 | 5 | 0 | 11.53M | $98.50M | +1 | −1 |
| Q2 2024 | 5 | — | 10.02M | $129.64M | — | — |
保有者情報 · Q3 2025
| # | 運用会社 | 株数 | Δ株式数 | 時価 | そのウェイト | 保有中 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Morgan Stanley ✦ | 7.69M | — | $112.59M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Morgan Stanley ✦ | 7.69M | — | $112.59M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Morgan Stanley ✦ | 7.69M | — | $112.59M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 7.69M | — | $112.59M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 7.69M | — | $112.59M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Morgan Stanley ✦ | 7.69M | — | $112.59M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Morgan Stanley ✦ | 7.69M | — | $112.59M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Morgan Stanley ✦ | 7.69M | — | $112.59M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Morgan Stanley ✦ | 7.69M | — | $112.59M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Goldman Sachs Group ✦ | 4.95M | — | $72.52M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Goldman Sachs Group ✦ | 4.95M | — | $72.52M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Goldman Sachs Group ✦ | 4.95M | — | $72.52M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 4.19M | +2.1% | $61.30M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 4.19M | +2.1% | $61.30M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 4.19M | +2.1% | $61.30M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 4.19M | +2.1% | $61.30M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 3.86M | +17.1% | $56.58M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 18 | BlackRock ✦ (パッシブ) | 3.31M | -6.8% | $48.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | BlackRock ✦ (パッシブ) | 3.31M | -6.8% | $48.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Arrowstreet Capital ✦ | 2.83M | +132.1% | $41.41M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | Millennium Management ✦ | 2.56M | -17.2% | $37.42M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 766.28K | +107.6% | $11.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 766.28K | +107.6% | $11.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 766.28K | +107.6% | $11.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 766.28K | +107.6% | $11.22M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 495.06K | — | $7.25M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 495.06K | — | $7.25M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 495.06K | — | $7.25M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 495.06K | — | $7.25M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 495.06K | — | $7.25M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 495.06K | — | $7.25M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 495.06K | — | $7.25M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 495.06K | — | $7.25M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 495.06K | — | $7.25M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 495.06K | — | $7.25M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 495.06K | — | $7.25M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 495.06K | — | $7.25M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 495.06K | — | $7.25M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 495.06K | — | $7.25M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 495.06K | — | $7.25M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 495.06K | — | $7.25M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 495.06K | — | $7.25M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 495.06K | — | $7.25M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | D. E. Shaw & Co. ✦ | 281.29K | 新規 | $4.12M | 0.0% | New | 1 | SEC ↗ |
| 45 | The Vanguard Group ✦ (パッシブ) | 101.87K | 0.0% | $1.49M | 0.0% | Held | 2 | SEC ↗ |
| 46 | Citadel Advisors ✦ | 75.62K | 新規 | $1.11M | 0.0% | New | 1 | SEC ↗ |
| 47 | Fisher Asset Management ✦ | 40.48K | -59.0% | $592,686 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 48 | Marshall Wace ✦ | 27.77K | 新規 | $406,494 | 0.0% | New | 1 | SEC ↗ |
| 49 | Marshall Wace ✦ | 27.77K | 新規 | $406,494 | 0.0% | New | 1 | SEC ↗ |
「当該ウェイト」= そのマネージャーの報告済み13F株式評価額に占めるポジションの割合（確信度の指標）。✦ = キュレーション済みマネージャー。
新規買い手
| D. E. Shaw & Co. | $4.12M | 0.0% |
| Citadel Advisors | $1.11M | 0.0% |
| Marshall Wace | $406,494 | 0.0% |
| Marshall Wace | $406,494 | 0.0% |
ポジション解消済み
| Adage Capital Partners | $39.17M | だった 0.1% |
市場全体のコンテキスト: 全13Fファイラー対象（SEC構造化データ、 Q1 2026): 356 保有者, 97.72M 株式数, $1.74B 報告済み. これは上記の追跡対象ユニバースの数値とは異なる、より古い期間のものであり、両者が混在することはありません。
共同保有が多い銘柄
この有価証券の追跡対象保有者が最も頻繁に保有する他の銘柄 — ファンダメンタルな関係ではなく、共同保有件数に基づきます。
市場内買い付け (P)
カバレッジ期間内にインサイダーによる市場内買い付けはありません。
市場内売却 (S)
Aug 19
Plump Andrew Stewart
Officer, Director · 19.65K 株 · $363,347
Aug 18
Greenway Nicola Deidre Petal
Officer · 12.98K 株 · $235,118
Aug 10
Bitetti Teresa Marie
Officer · 50.01K 株 · $855,205
Aug 10
Duprey Lauren Rusckowski
Officer · 47.59K 株 · $813,721
Aug 10
Farajallah Awny Samaan…
Officer · 14.01K 株 · $239,503
Aug 10
Furney Natalie Anne Marie
Officer · 30.87K 株 · $527,843
Aug 10
Greenway Nicola Deidre Petal
Officer · 975 株 · $17,062
Aug 10
Greenway Nicola Deidre Petal
Officer · 33.63K 株 · $588,715
Aug 10
Greenway Nicola Deidre Petal
Officer · 6.77K 株 · $115,835
Aug 10
Ibrahim Ramy Riad Ahmed
Officer · 7.28K 株 · $124,437
株式付与、権利行使および税務目的の株式差し引きは、買いや売りとして集計しません。 方法論